-
公开(公告)号:US20090221566A1
公开(公告)日:2009-09-03
申请号:US12090790
申请日:2006-10-05
IPC分类号: A61K31/537 , C07D265/02 , A61K31/535 , A61P25/00 , A61P11/06 , A61P11/08 , A61P17/00 , A61P17/06 , A61P19/02 , A61P19/10
CPC分类号: C07D265/02
摘要: The present invention relates to oxazine derivatives, which can be used as selective inhibitors of phosphodiesterase (PDE) type IV. Compounds disclosed herein can be useful in the treatment of CMS disorders, AIDS, asthma, arthritis, bronchitis, chronic obstructive pulmonary disease (COPD), psoriasis, allergic rhinitis, shock, atopic dermatitis, Crohn's disease, adult respiratory distress syndrome (ARDS), eosinophilic granuloma, allergic conjunctivitis, osteoarthritis, ulcerative colitis and other inflammatory diseases especially in humans. Processes for the preparation of disclosed compounds are provided, as well as pharmaceutical compositions containing the disclosed compounds, and their use as phosphodiesterase (PDE) type IV inhibitors.
摘要翻译: 本发明涉及恶嗪衍生物,其可用作IV型磷酸二酯酶(PDE)的选择性抑制剂。 本文公开的化合物可用于治疗CMS疾病,AIDS,哮喘,关节炎,支气管炎,慢性阻塞性肺疾病(COPD),牛皮癣,过敏性鼻炎,休克,特应性皮炎,克罗恩病,成人呼吸窘迫综合征(ARDS) 嗜酸粒细胞性肉芽肿,过敏性结膜炎,骨关节炎,溃疡性结肠炎和其他炎性疾病,特别是人类。 提供了制备所公开化合物的方法,以及含有所公开化合物的药物组合物及其作为磷酸二酯酶(PDE)IV型抑制剂的用途。
-
公开(公告)号:US20080280926A1
公开(公告)日:2008-11-13
申请号:US10596528
申请日:2004-12-16
申请人: Venkata P. Palle , Sarala Balachandran , Mohammad Salman , Gagan Kukreja , Lalit Kumar Baregama , Abhijit Ray , Sunanda Ghosh Dastidar
发明人: Venkata P. Palle , Sarala Balachandran , Mohammad Salman , Gagan Kukreja , Lalit Kumar Baregama , Abhijit Ray , Sunanda Ghosh Dastidar
IPC分类号: C07D473/34 , A61K31/52 , A61P37/00 , A61P29/00 , A61P31/12 , A61P11/00 , A61P19/02 , A61P1/00
CPC分类号: C07D473/00
摘要: The present invention relates to purine derivatives, which can be used as selective phosphodiesterase (PDE) type IV inhibitors. Compounds disclosed herein can be useful in the treatment of asthma, arthritis, bronchitis, chronic obstructive pulmonary disease (COPD), psoriasis, allergic rhinitis, shock, atopic dermatitis, Crohn's disease, adult respiratory distress syndrome (ARDS), eosinophilic granuloma, allergic conjunctivitis, osteoarthritis, ulcerative colitis and other inflammatory diseases especially in humans. Also provided are processes for the preparation of disclosed compounds, pharmaceutical composition containing the disclosed compounds and their use as selective phosphodiesterase (PDE) type IV inhibitors.
摘要翻译: 本发明涉及可用作选择性磷酸二酯酶(PDE)IV型抑制剂的嘌呤衍生物。 本文公开的化合物可用于治疗哮喘,关节炎,支气管炎,慢性阻塞性肺疾病(COPD),牛皮癣,过敏性鼻炎,休克,特应性皮炎,克罗恩病,成人呼吸窘迫综合征(ARDS),嗜酸性肉芽肿,过敏性结膜炎 ,骨关节炎,溃疡性结肠炎和其他炎性疾病,特别是人类。 还提供了制备所公开的化合物的方法,含有所公开的化合物的药物组合物及其作为选择性磷酸二酯酶(PDE)IV型抑制剂的用途。
-
公开(公告)号:US20080009535A1
公开(公告)日:2008-01-10
申请号:US11390491
申请日:2006-03-27
申请人: Sarala Balachandran , Nidhi Gupta , Nagarajan Muthukaman , Vinayak Khairnar , Sarika Ramnani , Lalit Baregama , Saswati Chakladar , Mandadapu Raghu Ramaiah , Ritu Agarwal , Sunanda Dastidar , Abhijit Ray
发明人: Sarala Balachandran , Nidhi Gupta , Nagarajan Muthukaman , Vinayak Khairnar , Sarika Ramnani , Lalit Baregama , Saswati Chakladar , Mandadapu Raghu Ramaiah , Ritu Agarwal , Sunanda Dastidar , Abhijit Ray
IPC分类号: A61K31/424 , A61P11/00 , A61P11/06 , A61P17/06 , A61P29/00 , A61P31/12 , C07D261/04
CPC分类号: C07D261/20 , C07D413/12 , C07D498/10
摘要: The present invention relates to isoxazoline derivatives, which can be used as selective inhibitors of phosphodiesterase (PDE) type IV. In particular, compounds disclosed herein can be useful in the treatment of AIDS, asthma, arthritis, bronchitis, chronic obstructive pulmonary disease (COPD), psoriasis, allergic rhinitis, shock, atopic dermatitis, Crohn's disease, adult respiratory distress syndrome (ARDS), eosinophilic granuloma, allergic conjunctivitis, osteoarthritis, ulcerative colitis and other inflammatory diseases in a patient, particularly in humans. The present invention also relates to processes for the preparation of disclosed compounds, as well as pharmaceutical compositions thereof, and their use as phosphodiesterase (PDE) type IV inhibitors.
摘要翻译: 本发明涉及异恶唑啉衍生物,其可用作IV型磷酸二酯酶(PDE)的选择性抑制剂。 特别地,本文公开的化合物可用于治疗AIDS,哮喘,关节炎,支气管炎,慢性阻塞性肺病(COPD),牛皮癣,过敏性鼻炎,休克,特应性皮炎,克罗恩病,成人呼吸窘迫综合征(ARDS) 嗜酸粒细胞肉芽肿,过敏性结膜炎,骨关节炎,溃疡性结肠炎和其他炎性疾病,特别是在人类中。 本发明还涉及制备所公开的化合物及其药物组合物及其作为磷酸二酯酶(PDE)IV型抑制剂的用途的方法。
-
公开(公告)号:US20070259874A1
公开(公告)日:2007-11-08
申请号:US10596059
申请日:2004-11-26
申请人: Venkata Palle , Sarala Balachandran , Nidhi Gupta , Gagan Kukreja , Manoj Khera , Lalit Baregama , Raghuramaiah Mandadapu , Abhijit Ray , Sunanda Dastidar
发明人: Venkata Palle , Sarala Balachandran , Nidhi Gupta , Gagan Kukreja , Manoj Khera , Lalit Baregama , Raghuramaiah Mandadapu , Abhijit Ray , Sunanda Dastidar
IPC分类号: A61K31/42 , A61K31/4245 , A61K31/433 , A61K31/5375 , A61P1/04 , A61P11/08 , A61P17/00 , A61P17/06 , A61P19/02 , A61P29/00 , A61P37/00 , A61P37/08 , A61P43/00 , A61P9/00 , C07D261/00 , C07D271/06 , C07D271/10 , C07D271/113 , C07D285/135 , C07D413/00
CPC分类号: C07D413/04 , C07D261/04 , C07D413/12 , C07D413/14 , C07D417/04
摘要: The present invention relates to isoxazoline derivatives and their analogues, which can be used as phosphodiesterase (PDE) type IV selective inhibitors. Compounds disclosed herein can be useful in the treatment of AIDS, asthma, arthritis, bronchitis, chronic obstructive pulmonary disease (COPD), psoriasis, allergic rhinitis, shock, atopic dermatitis, Crohn's disease, adult respiratory distress syndrome (ARDS), eosinophilic granuloma, allergic conjunctivitis, osteoarthritis, ulcerative colitis and other inflammatory diseases, especially in humans. Processes for the preparation of disclosed compounds, pharmaceutical compositions containing the disclosed compounds, and their use as PDE type IV selective inhibitors, are provided.
摘要翻译: 本发明涉及可用作磷酸二酯酶(PDE)IV型选择性抑制剂的异恶唑啉衍生物及其类似物。 本文公开的化合物可用于治疗AIDS,哮喘,关节炎,支气管炎,慢性阻塞性肺疾病(COPD),牛皮癣,过敏性鼻炎,休克,特应性皮炎,克罗恩病,成人呼吸窘迫综合征(ARDS),嗜酸粒细胞性肉芽肿, 过敏性结膜炎,骨关节炎,溃疡性结肠炎和其他炎性疾病,特别是人类。 提供制备所公开化合物的方法,含有所公开化合物的药物组合物及其作为PDE IV型选择性抑制剂的用途。
-
公开(公告)号:US20050075383A1
公开(公告)日:2005-04-07
申请号:US10930569
申请日:2004-08-30
申请人: Venkata Palle , Sarala Balachandran , Mohammad Salman , Gagan Kukreja , Nidhi Gupta , Abhijit Ray , Sunanda Dastidar
发明人: Venkata Palle , Sarala Balachandran , Mohammad Salman , Gagan Kukreja , Nidhi Gupta , Abhijit Ray , Sunanda Dastidar
IPC分类号: A61K31/42 , A61K31/422 , A61K31/423 , A61K31/424 , C07C45/61 , C07C269/06 , C07D261/02 , C07D261/04 , C07D261/20 , C07D413/06 , C07D413/14 , C07D487/08 , C07D491/02 , C07D498/10
CPC分类号: C07D261/04 , C07D498/10
摘要: The present invention relates to isoxazoline derivatives, which can be used as selective inhibitors of phosphodiesterase (PDE) type IV. In particular, compounds disclosed herein can be useful in the treatment of AIDS, asthma, arthritis, bronchitis, chronic obstructive pulmonary disease (COPD), psoriasis, allergic rhinitis, shock, atopic dermatitis, Crohn's disease, adult respiratory distress syndrome (ARDS), eosinophilic granuloma, allergic conjunctivitis, osteoarthritis, ulcerative colitis and other inflammatory diseases in a patient, particularly in humans. The present invention also relates to processes for the preparation of disclosed compounds, as well as pharmaceutical compositions thereof, and their use as phosphodiesterase (PDE) type IV inhibitors.
摘要翻译: 本发明涉及异恶唑啉衍生物,其可用作IV型磷酸二酯酶(PDE)的选择性抑制剂。 特别地,本文公开的化合物可用于治疗AIDS,哮喘,关节炎,支气管炎,慢性阻塞性肺病(COPD),牛皮癣,过敏性鼻炎,休克,特应性皮炎,克罗恩病,成人呼吸窘迫综合征(ARDS) 嗜酸粒细胞肉芽肿,过敏性结膜炎,骨关节炎,溃疡性结肠炎和其他炎性疾病,特别是在人类中。 本发明还涉及制备所公开的化合物及其药物组合物及其作为磷酸二酯酶(PDE)IV型抑制剂的用途的方法。
-
16.
公开(公告)号:US20080312285A1
公开(公告)日:2008-12-18
申请号:US12065819
申请日:2006-08-30
申请人: Venkata Palle , Sarala Balachandran , Lalit Kumar Baregama , Saswati Chakladar , Sarika Ramnani , Nagarajan Muthukamal , Abhijit Ray , Sunanda G. Dastidar
发明人: Venkata Palle , Sarala Balachandran , Lalit Kumar Baregama , Saswati Chakladar , Sarika Ramnani , Nagarajan Muthukamal , Abhijit Ray , Sunanda G. Dastidar
IPC分类号: A61K31/4439 , C07D413/10 , A61K31/422 , A61K31/4245 , A61P11/06 , C07D413/14 , A61P31/18
CPC分类号: C07D413/04 , C07D413/14
摘要: The present invention relates to isoxazoline derivatives of structure Ia, which can be used as selective inhibitors of phosphodiesterase (PDE) type IV. Compounds disclosed herein can be useful in the treatment of CNS disorders, AIDS, asthma, arthritis, bronchitis, chronic obstructive pulmonary disease (COPD), psoriasis, allergic rhinitis, shock, atopic dermatitis, Crohn's disease, adult respiratory distress syndrome (ARDS), eosinophilic granuloma, allergic conjunctivitis, osteoarthritis, ulcerative colitis and other inflammatory diseases especially in humans. Processes for the preparation of disclosed compounds are provided, as well as pharmaceutical compositions containing the disclosed compounds, and their use as phosphodiesterase (PDE) type IV inhibitors. Formula (Ia)
摘要翻译: 本发明涉及结构Ia的异恶唑啉衍生物,其可用作IV型磷酸二酯酶(PDE)的选择性抑制剂。 本文公开的化合物可用于治疗CNS疾病,AIDS,哮喘,关节炎,支气管炎,慢性阻塞性肺疾病(COPD),牛皮癣,过敏性鼻炎,休克,特应性皮炎,克罗恩病,成人呼吸窘迫综合征(ARDS) 嗜酸粒细胞性肉芽肿,过敏性结膜炎,骨关节炎,溃疡性结肠炎和其他炎性疾病,特别是人类。 提供了制备所公开化合物的方法,以及含有所公开化合物的药物组合物及其作为磷酸二酯酶(PDE)IV型抑制剂的用途。 式(Ia)
-
17.
公开(公告)号:US07781460B2
公开(公告)日:2010-08-24
申请号:US12065819
申请日:2006-08-30
申请人: Venkata Palle , Sarala Balachandran , Lalit Kumar Baregama , Saswati Chakladar , Sarika Ramnani , Nagarajan Muthukamal , Abhijit Ray , Sunanda G. Dastidar
发明人: Venkata Palle , Sarala Balachandran , Lalit Kumar Baregama , Saswati Chakladar , Sarika Ramnani , Nagarajan Muthukamal , Abhijit Ray , Sunanda G. Dastidar
IPC分类号: A61K31/443 , A61K31/416 , A61K31/422 , A61K31/427 , C07D413/04 , C07D271/06 , C07D271/10 , C07D261/04
CPC分类号: C07D413/04 , C07D413/14
摘要: The present invention relates to isoxazoline derivatives of structure Ia, which can be used as selective inhibitors of phosphodiesterase (PDE) type IV. Compounds disclosed herein can be useful in the treatment of CNS disorders, AIDS, asthma, arthritis, bronchitis, chronic obstructive pulmonary disease (COPD), psoriasis, allergic rhinitis, shock, atopic dermatitis, Crohn's disease, adult respiratory distress syndrome (ARDS), eosinophilic granuloma, allergic conjunctivitis, osteoarthritis, ulcerative colitis and other inflammatory diseases especially in humans. Processes for the preparation of disclosed compounds are provided, as well as pharmaceutical compositions containing the disclosed compounds, and their use as phosphodiesterase (PDE) type IV inhibitors.
摘要翻译: 本发明涉及结构Ia的异恶唑啉衍生物,其可用作IV型磷酸二酯酶(PDE)的选择性抑制剂。 本文公开的化合物可用于治疗CNS疾病,AIDS,哮喘,关节炎,支气管炎,慢性阻塞性肺疾病(COPD),牛皮癣,过敏性鼻炎,休克,特应性皮炎,克罗恩病,成人呼吸窘迫综合征(ARDS) 嗜酸粒细胞性肉芽肿,过敏性结膜炎,骨关节炎,溃疡性结肠炎和其他炎性疾病,特别是人类。 提供了制备所公开化合物的方法,以及含有所公开化合物的药物组合物及其作为磷酸二酯酶(PDE)IV型抑制剂的用途。
-
公开(公告)号:US20140045832A1
公开(公告)日:2014-02-13
申请号:US14113166
申请日:2012-04-19
申请人: Sarala Balachandran , Christopher J. Dinsmore , Abhijit Roychowdhury , Rajiv Sharma , Ram Asrey Vishwakarma
发明人: Sarala Balachandran , Christopher J. Dinsmore , Abhijit Roychowdhury , Rajiv Sharma , Ram Asrey Vishwakarma
IPC分类号: C07D413/14 , C07D413/12
CPC分类号: C07D413/14 , A61K31/5377 , A61K45/06 , C07D413/12
摘要: The present invention relates to compounds that are capable of inhibiting, modulating and/or regulating Insulin-Like-Growth Factor I Receptor and Insulin Receptor. The compounds of the instant invention possess a core structure that comprises a sulfonyl indole moiety. The present invention is also related to the pharmaceutically acceptable salts, hydrates and stereoisomers of these compounds.
摘要翻译: 本发明涉及能够抑制,调节和/或调节胰岛素样生长因子I受体和胰岛素受体的化合物。 本发明的化合物具有包含磺酰基吲哚部分的核心结构。 本发明还涉及这些化合物的药学上可接受的盐,水合物和立体异构体。
-
-
-
-
-
-
-